Hematopoietic Stem Cell Transplant (HSCT)

Ivosidenib as Post-HSCT Maintenance for AML

PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

Venetoclax Combined With Azacitidine for Consolidation Therapy in AML

Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Safety and Efficacy of FT14 Conditioning for Allogeneic HSCT in Acute Myeloid Leukemia

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation

Reduced-Intensity Conditioning (RIC) and Myeloablative Conditioning (MAC) for HSCT in AML/MDS

Developing Self-Management Interventions After HCT

Efficacy of N-acetylcysteine Versus Placebo as Prophylaxis of Sinusoidal Obstruction Syndrome in Patients Undergoing Hematopoietic Stem Cell Transplantation